Skip to main content
Clinical Trials/NCT05998369
NCT05998369
Completed
Not Applicable

Empowered Relief for Youth: A Feasibility Study of a Pain Management Class for Youth With Pain

Stanford University1 site in 1 country110 target enrollmentAugust 9, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Pain
Sponsor
Stanford University
Enrollment
110
Locations
1
Primary Endpoint
Treatment Expectancy Credibility (TEC-C)
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

The purpose of this pilot study is to examine the feasibility and preliminary efficacy of Empowered Relief for Youth with chronic pain (ER-Y). ER-Y is a single-session pain management class for youth focused on pain science education and teaching self-regulatory skills for pain management based on the evidence-based adult ER class. Feasibility and acceptability of ER-Y will be assessed post-class. Preliminary efficacy will be assessed by administering surveys at baseline, 4-weeks, 8-weeks, and 12-weeks post class.

Detailed Description

The current proposed, single-arm, uncontrolled pilot study will determine a) feasibility of ER-Y in youth with chronic pain, b) patients' perceptions and satisfaction of the ER-Y class and c) preliminary efficacy to inform the design of a subsequent randomized controlled trial.

Registry
clinicaltrials.gov
Start Date
August 9, 2023
End Date
April 1, 2025
Last Updated
7 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Laura E Simons

Professor

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Age at least 10 years old to 18 years
  • Diagnosis of Chronic Pain
  • English speaking

Exclusion Criteria

  • Significant psychosocial complexity (e.g., severe depression/ anxiety, unable to tolerate a group setting)
  • non-English Speaking

Outcomes

Primary Outcomes

Treatment Expectancy Credibility (TEC-C)

Time Frame: Immediately post class

The TEC-C assess treatment expectations and credibility with standardized sum scores from using a numeric rating scale (score 0 = "not at all" to 10 = "very much") with a higher score indicating high expectations.

Program Feedback Scale

Time Frame: Immediately post class

The Program Feedback Scale assesses participants agreement to seven statements indicating their perceived acceptability and feasibility based on a scale (score 0 = "really disagree" to 4 = "really agree") with a higher score indicating positive feedback and two open ended questions.

Secondary Outcomes

  • Pain Catastrophizing Scale (PCS)(Pre class, 4 weeks, 8 weeks, and 12 weeks post class)
  • Patient Global Impression of Change (PGIC)(4 weeks, 8 weeks, and 12 weeks post class)
  • PROMIS Pain Interference(Pre class, 4 weeks, 8 weeks, and 12 weeks post class)

Study Sites (1)

Loading locations...

Similar Trials